scholarly journals Umbilical cord occlusions in near-term ovine fetus induce increased beat-to-beat heart rate variability correlating to decreases in neuroinflammation: a case for the afferent cholinergic anti-inflammatory pathway?

2015 ◽  
Author(s):  
Martin G Frasch ◽  
Mark Szynkaruk ◽  
Andrew P Prout ◽  
Karen Nygard ◽  
Ruud Veldhuizen ◽  
...  

Neuroinflammation in utero may contribute to brain injury resulting in life long neurological disabilities. The pivotal role of the efferent cholinergic anti-inflammatory pathway (CAP) in controlling inflammation has been described in adults, but its importance in the fetus is unknown. Moreover, it is unknown whether CAP may also exert anti-inflammatory effects on the brain via CAP's afferent component of the vagus nerve. Based on multiple clinical studies in adults and our own work in fetal autonomic nervous system, we gauged the degree of CAP activity in vivo using heart rate variability measures reflecting fluctuations in vagus nerve activity. Measuring microglial activation in the ovine fetal brain near-term, we show in vivo that afferent fetal CAP may translate increased vagal cholinergic signaling into suppression of cerebral inflammation in response to near-term hypoxic acidemia as might occur during labour. Our findings suggest a new control mechanism of fetal neuroinflammation via the vagus nerve, providing novel possibilities for its non-invasive monitoring in utero and for targeted treatment.

2015 ◽  
Vol 49 ◽  
pp. 94-100 ◽  
Author(s):  
Timothy M. Cooper ◽  
Paula S. McKinley ◽  
Teresa E. Seeman ◽  
Tse-Hwei Choo ◽  
Seonjoo Lee ◽  
...  

1995 ◽  
Vol 82 (2) ◽  
pp. 521-530 ◽  
Author(s):  
Donald H. Penning ◽  
David H. Chestnut ◽  
Franklin Dexter ◽  
James Hrdy ◽  
Dan Poduska ◽  
...  

Background Glutamate has been implicated in the pathophysiology of neuronal injury associated with cerebral hypoxia-ischemia. A model using chronic in utero microdialysis was developed to sample the extracellular space of the fetal brain. Using this model, we tested the hypothesis that glutamate efflux from the parasagittal parietal cortex of near-term fetuses would increase during maternal hemorrhage. Methods Twelve near-term fetal sheep were instrumented with vascular catheters, and a microdialysis probe(s) was implanted into the parasagittal parietal cortex. After a 3-day recovery period, the animals were subjected to maternal hemorrhage until either the fetal pH was < 7.00 or the fetus died. The extracellular glutamate concentration in the collected dialysate was determined by high pressure liquid chromatography (HPLC). Results Maternal hemorrhage resulted in an 80-90% decrease in uterine blood flow, a decrease fetal po2, and a mixed metabolic and respiratory fetal acidosis. There were two groups of fetuses, survivors (n = 5) and nonsurvivors (n = 7). The nonsurvivor group showed a large increase (10-30-fold) in peak glutamate release (P = 0.0015). Survivors demonstrated a small (threefold) increase that was not statistically significant (P = 0.065), unless one animal with very low probe recovery was excluded (P = 0.0048). Conclusions Extracellular glutamate release from the fetal brain can occur during maternal hemorrhage with fetal acidemia. The pathophysiologic role (if any) of glutamate release in the survivors remains to be elucidated. Our results are consistent with the hypothesis that in utero release of glutamate occurs during periods of fetal asphyxia. This experimental preparation of chronic fetal brain microdialysis can be used to monitor the brain extracellular concentration of any dialyzable substance in response to stress, including maternal hemorrhage.


1994 ◽  
Vol 170 (5) ◽  
pp. 1425-1432 ◽  
Author(s):  
Donald H. Penning ◽  
Marjorie R. Grafe ◽  
Robert Hammond ◽  
Yoshio Matsuda ◽  
John Patrick ◽  
...  
Keyword(s):  
In Utero ◽  

2013 ◽  
Vol 27 (S1) ◽  
Author(s):  
Lucien Daniel Durosier ◽  
Alex Xu ◽  
Brad Matushewski ◽  
Mingju Cao ◽  
Christophe Herry ◽  
...  

2021 ◽  
Vol 11 ◽  
Author(s):  
Zhen Qin ◽  
Kefa Xiang ◽  
Ding-Feng Su ◽  
Yang Sun ◽  
Xia Liu

The outbreak of coronavirus disease 2019 (COVID-19) underlined the urgent need for alleviating cytokine storm. We propose here that activating the cholinergic anti-inflammatory pathway (CAP) is a potential therapeutic strategy. However, there is currently no approved drugs targeting the regulatory pathway. It is evident that nicotine, anisodamine and some herb medicine, activate the CAP and exert anti-inflammation action in vitro and in vivo. As the vagus nerve affects both inflammation and specific immune response, we propose that vagus nerve stimulation by invasive or non-invasive devices and acupuncture at ST36, PC6, or GV20, are also feasible approaches to activate the CAP and control COVID-19. It is worth to investigate the efficacy and safety of the strategy in patients with COVID-19.


1994 ◽  
Vol 170 (5) ◽  
pp. 1425-1432 ◽  
Author(s):  
Donald H. Penning ◽  
Marjorie R. Grafe ◽  
Robert Hammond ◽  
Yoshio Matsuda ◽  
John Patrick ◽  
...  
Keyword(s):  
In Utero ◽  

Sign in / Sign up

Export Citation Format

Share Document